Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation.Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000 American…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now